ARCHIVES

FDA Consider Regulation of CME Programs Paid for By Drug Companies; Goal To Limit Promotion

This article is from The Cancer Letter archive.

Vol. 18 No. 01 | January 3, 1992

Download PDF Visit The Full Archive

Related Articles

Diane Fink Accepts VP Job With ACS

April 3, 1981

PBS Runs Misleading Lung Screening Claim; Reporter and Subject on Mount Sinai Faculty

October 11, 2013

Organ Systems Program Defenders Go On Offense At NCAB Committee Meeting

December 11, 1987

Tamoxifen: No Mortality Benefit For Most “High Risk” Women

September 29, 2006

Conversation With The Cancer Letter: Wicha to Leave Director’s Job at UMich

November 8, 2013

President’s Cancer Panel urges comprehensive health care reform, provision of services for cancer survivors.

June 4, 2004